A new study shows deportation of undocumented migrants reduces housing construction by diminishing the supply of workers ...

A rare coalition of Republican Senate candidates running in crucial swing states issued a joint statement slamming Judge Juan ...

On April 23, 2024, the FTC issued a final rule banning employers from enforcing non-competes. Legal challenges—including from ...

Developing nerve cells outside the brain is where neuroblastoma, a common childhood disease, starts. Over 40 per cent of ...

Basil is a beginner-friendly, rewarding herb to grow, but you should avoid placing it next to these plant species if you want ...

A new Cambridge biotech incubated at GV (Google Ventures) has launched with a $67 million Series A funding and a new — ...

An entirely new approach to inhibiting DNA-cleaving enzymes works through the aggregation of an otherwise non-toxic molecule.

An entirely new approach to inhibiting DNA-cleaving enzymes works through the aggregation of an otherwise non-toxic molecule.

Kurome Therapeutics Inc. along with the Cincinnati Children’s Hospital Medical Center and U.S. Department of Health and Human Services have patented interleukin-1 receptor-associated kinase (IRAK) and ...

Discover the groundbreaking patent by Alnylam Pharmaceuticals Inc for a dsRNA molecule targeting Serum Amyloid A gene expression. Learn about the innovative design and potential applications in ...

The phrase “Free Palestine” has become ubiquitous. It is the battle cry on many a college campus and city street, spray-painted on Jewish community centers, synagogues, and random walls ...

Auron Therapeutics, a biotechnology company focused on developing next-generation targeted therapies by identifying and inhibiting the oncogenic cell states of cancer, today announced an oral ...